| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/22/2007 | CN101019931A Natural antibiotic composition extracted from crinite seed and its extraction process |
| 08/22/2007 | CN101019922A Chinese medicine composition soft capsule for treating hepatitis |
| 08/22/2007 | CN101019918A Natural antibiotic composition extracted from rust-colored crotalaria herb and its extraction process |
| 08/22/2007 | CN101019913A Externally applied medicine for treating herpes zoster |
| 08/22/2007 | CN101019912A Honeysuckle organic acid and its prepn process and dection and analysis method |
| 08/22/2007 | CN101019909A Supercritical safflower extracting process |
| 08/22/2007 | CN101019896A Chinese medicine composition for treating hepatitis |
| 08/22/2007 | CN101019891A Toad skin total alkaloid and its prepn, analysis and prepn process |
| 08/22/2007 | CN101019877A Soluble mangiferin clathrate and its prepn |
| 08/22/2007 | CN101019876A Compound roxithromycin dispersing tablet and its prepn |
| 08/22/2007 | CN101019875A Application of sophorolipid in preparing antibiotic medicine |
| 08/22/2007 | CN101019866A Medicine for treating hepatitis B |
| 08/22/2007 | CN101019864A Nifuratel for treating oral cavity infection |
| 08/22/2007 | CN101019861A New use of norsantharidin and its derivative in preventing and treating AIDS |
| 08/22/2007 | CN101019843A Application of hypericin in preventing and treating swine PC and PRRS |
| 08/22/2007 | CN101019842A Application of curcumin in preparing medicine for treating IIIV-1 relevant cognitive disorder |
| 08/22/2007 | CN101019608A Chinese herbal medicine mixture for feed |
| 08/21/2007 | US7259265 Coumarin compounds and method for preparing and using the same |
| 08/21/2007 | US7259247 Against the costimulatory surface molecule, natural or synthetic ligands, agonists or antagonists of the surface molecule. |
| 08/21/2007 | US7259179 Kinase inhibitors |
| 08/21/2007 | US7259163 Viricides against herpes virus |
| 08/21/2007 | US7259162 Benzazole derivatives and their use as JNK modulators |
| 08/21/2007 | US7259148 Hepatoprotective activity of 2′-p-hydroxybenzoylmussaenosidic acid |
| 08/21/2007 | US7259012 Use of oxidized lipoproteins for differentiation of precursor cells into mature dendritic cells |
| 08/21/2007 | US7259009 Self-rearranging DNA vectors |
| 08/21/2007 | US7258992 Reacting biological sample with a multiple epitope fusion polypeptide, detecting the presence or absence of complex, and thereby detecting the presence or absence of Streptococcus antibodies in sample |
| 08/21/2007 | US7258866 M. canis-containing ringworm vaccine |
| 08/21/2007 | US7258863 Heterologous protection induced by immunization with invaplex vaccine |
| 08/21/2007 | CA2387600C Novel fusidic acid derivatives |
| 08/21/2007 | CA2315827C Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 08/21/2007 | CA2150940C Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| 08/21/2007 | CA2099589C Enantiomerically pure .beta.-d-(-)-dioxolane-nucleosides |
| 08/21/2007 | CA2099069C Recombinant feline herpesvirus vaccine |
| 08/16/2007 | WO2007092888A2 Hcv ns5b inhibitors |
| 08/16/2007 | WO2007092802A1 Method for treating hiv infection through co-administration of tipranavir and gs 9137 |
| 08/16/2007 | WO2007092645A2 Novel hcv inhibitor combinations and methods |
| 08/16/2007 | WO2007092558A2 Sulfonamide derivatives to treat infection with hepatitis c virus |
| 08/16/2007 | WO2007092000A1 Inhibitors of hcv replication |
| 08/16/2007 | WO2007091959A1 Novel antimicrobial peptides and use thereof |
| 08/16/2007 | WO2007091958A1 Novel antimicrobial peptides and use thereof |
| 08/16/2007 | WO2007091644A1 Fungal growth inhibitor |
| 08/16/2007 | WO2007091624A1 Novel viral vector |
| 08/16/2007 | WO2007091580A1 Novel vaccine carrier |
| 08/16/2007 | WO2007091395A1 Method or agent for inhibiting the function of efflux pump of pseudomonas aeruginosa |
| 08/16/2007 | WO2007091393A1 10a-AZALIDE COMPOUND |
| 08/16/2007 | WO2007091147A1 Oxazolidinones containing oxindoles as antibacterial agents |
| 08/16/2007 | WO2007091037A2 Metal-containing virucidal compositions and uses |
| 08/16/2007 | WO2007090751A1 Heterobicyclic amide derivatives |
| 08/16/2007 | WO2007075794A3 Oral formulations comprising tigecycline |
| 08/16/2007 | WO2007064844A3 Anti-viral griffithsin compounds, compositions, and methods of use |
| 08/16/2007 | WO2007019397A3 6-membered aryl and heteroaryl derivatives for the treatment of hepatitis c virus |
| 08/16/2007 | WO2006124753A3 Antipyretic agents against vr1-antagonist-induced increases in body temperature |
| 08/16/2007 | WO2006115509A3 Small molecule immunopotentiators and assays for their detection |
| 08/16/2007 | WO2006093784A3 Dosage forms of antibiotics and combinations of antibiotics ans symptomatic relief agents |
| 08/16/2007 | WO2006055660A3 Method for treating hiv infection through co-administration of tipranavir and uk-427, 857 |
| 08/16/2007 | WO2004007437A9 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 08/16/2007 | US20070192906 Rice plant having vaccine gene transferred thereinto |
| 08/16/2007 | US20070191407 catalytic chemical preparation of intermediate 4-(2-cyanoethenyl)-2,6-dimethylbenzenamine stereoisomers in presence of palladium chloride; having HIV inhibiting properties |
| 08/16/2007 | US20070191395 Heterocyclic compounds having antifungal activity |
| 08/16/2007 | US20070191387 Substituted dihydroquinazolines |
| 08/16/2007 | US20070191386 Bicyclo-pyrazole compounds specially pyrrolo[3,4-c]pyrazole or tetrahydropyridine[4,3-c]pyrazole derivatives; anticarcinogenic agents; N-{5-phenylacetyl-4,6-dihydropyrrolo[3,4-c]pyrazol-3-yl}phenylacetamide; modulators of apoptosis; combinatorial chemical library with an isocyanate polystyrenic resin |
| 08/16/2007 | US20070191373 Heterocyclic compounds for use in the treatment of viral infections |
| 08/16/2007 | US20070191360 antitumor agents; viricides |
| 08/16/2007 | US20070191347 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 08/16/2007 | US20070191312 Novel heterocyclic compounds, preparation process and intermediates, and use as medicaments, in particular as beta-lactamase inhibitors and antibacterials |
| 08/16/2007 | US20070191291 Compound antibacterial drugs comprising n-acetyl-d-glucosamine |
| 08/16/2007 | US20070191288 Treatments for Benign Tumors, Cancers, Neoplasias, and/or Other Inflammatory Disorders or Diseases |
| 08/16/2007 | US20070191280 High Purity Lipopeptides |
| 08/16/2007 | US20070191265 Anti-HIV Agent |
| 08/16/2007 | US20070190652 Anti-HIV Agent |
| 08/16/2007 | US20070190634 Compositions useful as inhibitors of protein kinases |
| 08/16/2007 | US20070190612 31 Human Secreted Proteins |
| 08/16/2007 | US20070190523 Method and compositions for identifying anti-hiv therapeutic compounds |
| 08/16/2007 | US20070190158 Pharmaceutical compositions in particulate form |
| 08/16/2007 | US20070190132 Pharmaceutical compositions for oral and topical administration |
| 08/16/2007 | US20070190106 Phosphorus-containing compounds & uses thereof |
| 08/16/2007 | US20070190077 Anti-HIV agents |
| 08/16/2007 | US20070190076 A bacterial preparation consisting of freeze dried, non-denatured Mycobacterium bovis and water, in an amount effective to stimulate leukocytic regulatory cells, used for the prevention and/or the treatment of cancer, autoimmune diseases, allergies and tuberculosis; vaccines |
| 08/16/2007 | US20070190074 Modified hpv e6 and e7 genes and proteins useful for vaccination |
| 08/16/2007 | US20070190073 Bioconjugation; stimulates production of Th1-associated cytokines, lymphocytes, suppresses production of allergen-specific antibodies, reduces allergen-stimulated IgE production |
| 08/16/2007 | US20070190071 9-Substituted 8-oxoadenine compound |
| 08/16/2007 | US20070190054 Prevention and treatment of complement-associated disorders |
| 08/16/2007 | US20070190033 treatment of a bacterial infection characterized by biofilm formation; for Pseudomonas aeruginosa infections such as those in canine ears |
| 08/16/2007 | DE60127731T2 Probiotica zur Verwendung als Futter für Haustiere Probiotics for use as food for pets |
| 08/16/2007 | DE102006017600A1 Nucleosidanaloga als Genexpressionsregulatoren bei Viren Nucleoside analogs as regulators of gene expression in viruses |
| 08/16/2007 | DE102006006196A1 Nucleosidanaloga als Auslöser der Fehlerkatastrophe bei Viren Nucleoside analogs as the cause of the error catastrophe for viruses |
| 08/16/2007 | CA2641988A1 Method or agent for inhibiting the function of efflux pump of pseudomonas aeruginosa |
| 08/16/2007 | CA2641859A1 Combinations comprising hcv protease inhibitor(s) and hcv polymerase inhibitor(s), and methods of treatment related thereto |
| 08/16/2007 | CA2641854A1 Neutralization of bacterial spores |
| 08/16/2007 | CA2641502A1 Metal-containing virucidal compositions and uses |
| 08/16/2007 | CA2641388A1 Inhibition of hiv infection through chemoprophylaxis |
| 08/16/2007 | CA2641055A1 Heterobicyclic amide derivatives |
| 08/16/2007 | CA2640229A1 Sulfonamide derivatives to treat infection with hepatitis c virus |
| 08/16/2007 | CA2637221A1 Novel antimicrobial peptides and use thereof |
| 08/16/2007 | CA2637216A1 Novel antimicrobial peptides and use thereof |
| 08/16/2007 | CA2637204A1 Substituted quinolones iii |
| 08/16/2007 | CA2637158A1 Oxazolidinones containing oxindoles as antibacterial agents |
| 08/16/2007 | CA2636632A1 Novel viral vector |
| 08/15/2007 | EP1818409A1 Transfer of mRNAusing polycationic compounds |
| 08/15/2007 | EP1818406A1 Gene construction, vector and dna vaccine for the vaccination of aquatic animals |